Home/Filings/4/0001780662-25-000003
4//SEC Filing

PISKEL KYLE 4

Accession 0001780662-25-000003

CIK 0001478320other

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 6:45 PM ET

Size

16.8 KB

Accession

0001780662-25-000003

Insider Transaction Report

Form 4
Period: 2025-11-28
PISKEL KYLE
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-28$6.55/sh+11,980$78,469281,323 total
  • Exercise/Conversion

    Common Stock

    2025-11-28$7.80/sh+3,750$29,250285,073 total
  • Exercise/Conversion

    Common Stock

    2025-11-28$12.14/sh+94,384$1,145,822379,457 total
  • Sale

    Common Stock

    2025-11-28$19.50/sh162,820$3,174,990216,637 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-11-2811,9800 total
    Exercise: $6.55Exp: 2028-10-01Common Stock (11,980 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-11-283,7500 total
    Exercise: $7.80Exp: 2029-04-23Common Stock (3,750 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-11-2894,3848,581 total
    Exercise: $12.14Exp: 2032-03-04Common Stock (94,384 underlying)
Footnotes (4)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2025.
  • [F2]The price reported for this transaction is a weighted -average price. The shares were sold in multiple transactions ranging from $19.28 to $19.72, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
  • [F3]The option is fully vested and exercisable.
  • [F4]The options vested with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.

Issuer

Adaptive Biotechnologies Corp

CIK 0001478320

Entity typeother

Related Parties

1
  • filerCIK 0001780662

Filing Metadata

Form type
4
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 6:45 PM ET
Size
16.8 KB